REST has also been implicated as a tumor suppressor in breast cancer, colorectal cancer and small cell lung cancer, and as an oncogene in neuroblastomas, medulloblastomas and pheochromocytomas, which are associated with von Hippel-Lindau syndrome [9], [10]. This evidence concerns the gene REST and neuroblastoma.